Literature DB >> 12576966

Endotoxin increases both protein and fluid microvascular permeability in cat skeletal muscle.

Staffan Holbeck1, Per-Olof Grände.   

Abstract

OBJECTIVE: To evaluate effects of lipopolysaccharide (endotoxin) on protein and fluid permeability in a whole organ skeletal muscle preparation.
DESIGN: Controlled, prospective laboratory study.
SETTING: University research laboratory.
SUBJECTS: Eleven adult male cats.
INTERVENTIONS: The study was performed on the autoperfused and denervated calf muscles of the cat hindlimb placed in a fluid-filled plethysmograph. The endotoxin-induced change in the osmotic reflection coefficient for albumin was used as a measure of alteration in protein permeability of the microvascular wall, and the simultaneous change in capillary filtration coefficient was used as a measure of alteration in fluid permeability. Endotoxin as a bolus infusion (1 mg/kg iv) was given to six cats, and another five cats given only the vehicle (NaCl) were used as control.
MEASUREMENTS AND MAIN RESULTS: Arterial blood flow, arterial and venous blood pressures, total vascular resistance, and tissue volume changes were measured continuously. The ratio between the osmotic reflection coefficients for albumin on two occasions (before and about 1.5 hr after endotoxin infusion) was calculated from the Starling fluid equilibrium equation. This was performed by measurement of the maximum absorption rate from an isovolumetric state by an intravenous bolus infusion of 20% human albumin (0.6 g/kg) and the capillary filtration coefficient. Albumin concentrations were measured before and after the albumin infusion to correct for effects of difference in plasma volume on the induced increase in colloid osmotic pressure. We found that the osmotic reflection coefficient for albumin was reduced by 30% (p <.05), and the capillary filtration coefficient was increased by 31% (p <.05) by endotoxin. No changes were seen in the vehicle experiments.
CONCLUSION: Endotoxin causes a significant increase in both protein and fluid microvascular wall permeability. These effects may explain the marked leakage of plasma to the interstitium that is often seen in critically ill patients with sepsis and systemic inflammatory response syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576966     DOI: 10.1097/01.CCM.0000048620.88344.70

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Modulation of endothelial monolayer permeability induced by plasma obtained from lipopolysaccharide-stimulated whole blood.

Authors:  A Nooteboom; R P Bleichrodt; T Hendriks
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock.

Authors:  Roberto Alberto De Blasi; Stefano Palmisani; Daniela Alampi; Marco Mercieri; Rocco Romano; Saul Collini; Giovanni Pinto
Journal:  Intensive Care Med       Date:  2005-10-05       Impact factor: 17.440

3.  Rapid changes in the microvascular circulation of skeletal muscle impair insulin delivery during sepsis.

Authors:  Nicholas A Mignemi; P Mason McClatchey; Kameron V Kilchrist; Ian M Williams; Bryan A Millis; Kristen E Syring; Craig L Duvall; David H Wasserman; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-12       Impact factor: 4.310

4.  Ascorbate protects endothelial barrier function during septic insult: Role of protein phosphatase type 2A.

Authors:  Min Han; Suresh Pendem; Suet Ling Teh; Dinesh K Sukumaran; Feng Wu; John X Wilson
Journal:  Free Radic Biol Med       Date:  2009-10-17       Impact factor: 7.376

5.  Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation.

Authors:  Feng Wu; Min Han; John X Wilson
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

6.  Microvascular permeability during experimental human endotoxemia: an open intervention study.

Authors:  Lucas T G J van Eijk; Peter Pickkers; Paul Smits; Wim van den Broek; Martijn P W J M Bouw; Johannes G van der Hoeven
Journal:  Crit Care       Date:  2005-02-21       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.